nitroaspirin has been researched along with Injury, Myocardial Reperfusion in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, SG; Furman, BL; Vojnovic, I; Wainwright, CL; Warner, T; Watson, DG | 1 |
| Colantuono, G; Khan, M; Kumbala, D; Kuppusamy, P; Kutala, VK; Mandal, R; Potaraju, V | 1 |
| Chen, WL; Fu, Y; Moore, PK; Wang, Z; Zhu, YZ | 1 |
| Bernareggi, M; Berti, F; Berti, M; Colonna, VD; Del Soldato, P; Rossoni, G | 1 |
| Del Soldato, P; Miller, AM; Wainwright, CL; Work, LM | 1 |
5 other study(ies) available for nitroaspirin and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
The effect of NCX4016 [2-acetoxy-benzoate 2-(2-nitroxymethyl)-phenyl ester] on the consequences of ischemia and reperfusion in the streptozotocin diabetic rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Pressure; Calcimycin; Diabetes Mellitus, Experimental; Heart Rate; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Rats; Rats, Sprague-Dawley; Streptozocin | 2006 |
Prevention of postischemic myocardial reperfusion injury by the combined treatment of NCX-4016 and Tempol.
Topics: Animals; Aspirin; Creatine Kinase; Cyclic N-Oxides; L-Lactate Dehydrogenase; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Spin Labels; Superoxide Dismutase; Superoxides; Uric Acid | 2006 |
Cardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Pressure; Cyclooxygenase 1; Cyclooxygenase 2; Enzyme Inhibitors; Heart Rate; Male; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Ventricular Dysfunction, Left; Ventricular Function, Left | 2007 |
Myocardial protection by the nitroderivative of aspirin, NCX 4016: in vitro and in vivo experiments in the rabbit.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Aspirin; Creatine Kinase; Dose-Response Relationship, Drug; Electrocardiography; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Peroxidase; Rabbits; Vasoconstrictor Agents; Ventricular Function, Left | 2000 |
NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arrhythmias, Cardiac; Aspirin; Coronary Disease; Endothelium, Vascular; Hemodynamics; Leukocytes; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Aggregation; Swine; Thromboxane B2; Ventricular Fibrillation | 2002 |